02-Feb-2024
2 mins read
The Board of Directors of Dipna Pharmachem Ltd has recently declared a Rights Issue involving up to 1,29,67,500 equity shares, each with a nominal value of Rs 10. This issuance, priced at Rs 10 per share, aims to raise a total of Rs 12,96,75,000. This right issue will open on February 26, 2024 and closes on March 7, 2024. The offer is exclusively available to the current, qualified equity shareholders of the company under the Rights Issue framework.
Dipna Pharmachem Ltd Product Portfolio
Founded in 2011, Dipna Pharmachem Limited (DPL) is a corporation based in India that specialises in the trade, importation, and exportation of industrial chemicals and pharmaceutical ingredients. Its product lineup encompasses active pharmaceutical ingredients (APIs), excipients, and various chemical formulation products. Dipna Pharmachem Limited operates on a global scale, offering import and export services to an international clientele.
The company boasts a diverse portfolio, including specialised knowledge in the marketing and procurement of industrial chemicals, pharmaceutical raw materials, APIs, and solvents, as well as formulation and intermediates. Additionally, it offers support in establishing contract manufacturing compliance for pharmaceutical companies operating in both regulated and semi-regulated markets, ensuring adherence to international standards and achievement of certifications such as WHO-GMP.
Financial Performance of Dipna Pharmachem Ltd (In Rs Crore)
Between the fiscal years ending on March 31, 2023, and March 31, 2022, Dipna Pharmachem Ltd. saw its revenue rise by 37.34%, while its profit after tax (PAT) experienced a decrease of 21.85%.
| Period Ended | 31-Mar-23 | 31-Mar-22 |
| Assets | 77.56 | 36.23 |
| Revenue | 99.93 | 72.77 |
| Profit After Tax | 0.91 | 1.17 |
| Reserves and Surplus | 12.39 | 1.7 |
Important Details of Dipna Pharmachem Ltd Rights Issue 2024
| Issue Open | February 26, 2024 – March 7, 2024 |
| Security Name | Dipna Pharmachem Ltd |
| Issue Size (Shares) | 12,967,500 |
| Issue Size (Amount) | Rs 12.97 Crores |
| Issue Price | Rs 10 per share |
| Face Value | Rs 10 per share |
| Listing At | BSE |
| Terms of Payment | Yet to be announced |
| Entitlement | 13 Rights Equity Share(s) for every 12 fully paid-up Equity Shares held on Record Date |
Timetable of Dipna Pharmachem Ltd Rights Issue 2024
| Last Date to buy shares | 5-Feb-24 |
| Record Date | 6-Feb-24 |
| Credit of Rights Entitlements | Yet to be announced |
| Bid/Offer Opens On | 26-Feb-24 |
| Renunciation of Rights Entitlements | 4-Mar-24 |
| Bid/Offer Closes On | 7-Mar-24 |
| Deemed Date of Allotment | Yet to be announced |
| Credit Date | Yet to be announced |
| Listing Date | Yet to be announced |
The Objectives of Dipna Pharmachem Ltd Rights Issue 2024
The objectives of Dipna Pharmachem Ltd Rights Issue 2024 are yet to be announced.
Dipna Pharmachem Rights Issue 2024 Lead Manager(s)
The lead manager(s) of Dipna Pharmachem Ltd Rights Issue 2024 is yet to be announced.
How to Apply for Dipna Pharmachem Ltd Rights Issue 2024
Wait for the public issue to open for subscription, then click here to apply for the Dipna Pharmachem Ltd Rights Issue 2024 with Bigul.
How to Check Allotment Status of Dipna Pharmachem Ltd Rights Issue 2024
The registrar for Dipna Pharmachem Ltd Rights Issue 2024 is Bigshare Services Private Limited. Stay tuned with Bigul for future updates.
FAQs
- What are the details of Dipna Pharmachem Ltd Right Issue 2024?
The Rights Issue for Dipna Pharmachem Ltd in 2024 has an offering of up to 1,29,67,500 equity shares, each with a face value of Rs 10, at an issue price of Rs 10 per share. This move aims to raise a total of Rs 12,96,75,000 and is exclusively available to the company’s current, qualified equity shareholders.
- What is Dipna Pharmachem Ltd product portfolio?
Dipna Pharmachem Ltd specialises in the trading, importing, and exporting of industrial chemicals and pharmaceutical raw materials, including active pharmaceutical ingredients (APIs), excipients, chemical formulations, solvents, and intermediates. The company, established in 2011, offers global import and export services and supports pharmaceutical companies with contract manufacturing compliance for regulated and semi-regulated markets.
- How did Dipna Pharmachem Ltd perform financially between the fiscal years ending March 31, 2023, and March 31, 2022?
During this period, Dipna Pharmachem Ltd experienced a 37.34% increase in revenue, while its profit after tax (PAT) saw a decrease of 21.85%. The company’s assets and reserves also showed significant changes.
- What are the key dates and details for the Dipna Pharmachem Ltd Rights Issue 2024?
The issue size is 12,967,500 shares, totalling Rs 12.97 crores, with each share priced at Rs 10. The face value per share is also Rs 10, and it will be listed on the BSE. Key dates, including the last date to buy shares, Issue opening and closing dates and the record date have been announced and you can check it in the above timetable.
- How can one apply for the Dipna Pharmachem Ltd Rights Issue 2024?
Interested shareholders can apply for the Rights Issue when it opens for subscription by using the provided link to Bigul’s platform. It’s essential to wait for the issue to officially open before applying.
- Where can one check the allotment status for the Dipna Pharmachem Ltd Rights Issue 2024?
The allotment status can be checked by clicking here. Stay updated with Bigul for the latest information on the allotment status and other details.